Changes

no edit summary
Line 9: Line 9:  
New Volunteer Form: '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''
 
New Volunteer Form: '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''
   −
Video Tutorial (how to create content in the CCGA): '''<u>[[Video_Tutorial|Video Tutorial]]</u>'''
+
Video Tutorial (how to create content in the CCGA): '''<u>[[Video_Tutorial|Video Tutorial]]</u>''' (in process of being updated)
    
Author Instructions (includes links to Word versions of CCGA page templates, how to curate a gene page, and the policy for inclusion of figures): '''<u>[[Author Instructions|Author Instructions]]</u>'''
 
Author Instructions (includes links to Word versions of CCGA page templates, how to curate a gene page, and the policy for inclusion of figures): '''<u>[[Author Instructions|Author Instructions]]</u>'''
Line 50: Line 50:  
3.    Can I get academic credit for this work?
 
3.    Can I get academic credit for this work?
   −
''Please see the author instructions for details on how to cite a CCGA page on your CV and in reports or other media ('''<u>[[Author Instructions|Author Instructions]]</u>'''). In addition, we will be acknowledging authors in CCGA presentations and we’re developing other ways of thanking our contributors such as through social media [https://twitter.com/ccgawiki '''@ccgawiki'''].''  
+
''Please see the '''<u>[[Author Instructions|Author Instructions]]</u>''' for details on how to cite a CCGA page on your CV and in reports or other media. In addition, we will be acknowledging authors in CCGA presentations and we’re developing other ways of thanking our contributors such as through social media [https://twitter.com/ccgawiki '''@ccgawiki'''].''  
      Line 65: Line 65:  
''6.    '' What are the requirements for a mentor?  
 
''6.    '' What are the requirements for a mentor?  
   −
''The mentor is typically an existing member of the CCGA and/or a qualified individual with expertise in the field who becomes a CCGA member through the mentoring process. See also the [[Description of CCGA Roles]].''  
+
''The mentor is typically an existing member of the CCGA and/or a qualified individual with expertise in the field who becomes a CCGA member through the mentoring process. See also the [[Description of CCGA Roles|'''<u>Description of CCGA Roles</u>''']].''  
       
''7.    '' What are the different volunteer opportunities available within the CCGA?  
 
''7.    '' What are the different volunteer opportunities available within the CCGA?  
   −
''We are currently recruiting authors to write CCGA pages and Associate Editors for disease-specific areas. In the future we may have additional openings on our other initiatives, and so please stay tuned for further news. If you would like to be considered for opportunities in addition to authorship, please indicate this information on the '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. See also the [[Description of CCGA Roles]].''
+
''We are currently recruiting authors to write CCGA pages and Associate Editors for disease-specific areas. In the future we may have additional openings on our other initiatives, and so please stay tuned for further news. If you would like to be considered for opportunities in addition to authorship, please indicate this information on the '''[https://mms.cancergenomics.org/members/form.php?orgcode=CGC&fid=3830649 <u>Volunteer Form</u>]'''. See also the [[Description of CCGA Roles|'''<u>Description of CCGA Roles</u>''']].''
      Line 77: Line 77:  
''There are three types of pages:''
 
''There are three types of pages:''
   −
''(1)   Disease category overview pages (for example see '''<u>[[Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
+
''(1)   Disease category overview pages (for example see '''<u>[[HAEM4:Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms|Acute Myeloid Leukemia (AML)]]</u>''', which are summaries of a group of diseases with links to all relevant content.''
    
''(2)   Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
 
''(2)   Disease-specific pages (for example see any of the links on the AML overview page), which is for individual disease entities and much more detailed.''
Line 125: Line 125:     
''Please discuss with the Associate Editor for your area as they will work with you to find a timeline that makes sense for you.''  
 
''Please discuss with the Associate Editor for your area as they will work with you to find a timeline that makes sense for you.''  
 +
 +
17.    Can I modify a page that has already been completed by other authors?
 +
 +
''Yes! The CCGA is a wiki-based platform with the intention that contributors can modify any page at any time if something is not accurate or new evidence and references would be beneficial to share. This will allow up-to-date accurate content to be available to the community. Primary authorship will typically be listed as those individuals that initially completed the page content, and inquiries can be made by [Mailto:CCGA@cancergenomics.org <u>Email</u>] if a subsequent user modifies the content and feels the effort put forth is of high enough significance to warrant listing in the authorship section.''
       
'''<u>Technical Issues</u>'''
 
'''<u>Technical Issues</u>'''
   −
17.  What should I do if I am experience technical issues when uploading content or using the site?
+
18.  What should I do if I am experience technical issues when uploading content or using the site?
    
''Please contact your Associate Editor who can either resolve your issue or follow up with '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' for technical assistance. If you have a major technical issue or something time sensitive, please include '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' on your initial email to your Associate Editor.''
 
''Please contact your Associate Editor who can either resolve your issue or follow up with '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' for technical assistance. If you have a major technical issue or something time sensitive, please include '''[Mailto:CCGA@cancergenomics.org <u>CCGA@cancergenomics.org </u>]''' on your initial email to your Associate Editor.''